Viral infection and host immune response in diabetes
IUBMB Life · 2024
DOI: 10.1002/iub.2794 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IUBMB Life, 2024. Verfasst von Garima Joshi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 233 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes, a chronic metabolic disorder disrupting blood sugar regulation, has emerged as a prominent silent pandemic. Uncontrolled diabetes predisposes an individual to develop fatal complications like cardiovascular disorders, kidney damage, and neuropathies and aggravates the severity of treatable infections. Escalating cases of Type 1 and Type 2 diabetes correlate with a global upswing in diabetes‐linked mortality. As a growing global concern with limited preventive interventions, diabetes necessitates extensive research to mitigate its healthcare burden and assist ailing patients. An altered immune system exacerbated by chronic hyperinflammation heightens the susceptibility of diabetic individuals to microbial infections, including notable viruses like SARS‐CoV‐2, dengue, and influenza. Given such a scenario, we scrutinized the literature and compiled molecular pathways and signaling cascades related to immune compartments in diabetics that escalate the severity associated with the above‐mentioned viral infections in them as compared to healthy individuals. The pathogenesis of these viral infections that trigger diabetes compromises both innate and adaptive immune functions and pre‐existing diabetes also leads to heightened disease severity. Lastly, this review succinctly outlines available treatments for diabetics, which may hold promise as preventive or supportive measures to effectively combat these viral infections in the former.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India.
ORCID-Profile: Prasenjit Guchhait
Zitieren
APA
Joshi, G., Das, A., Verma, G., & Guchhait, P. (2024). Viral infection and host immune response in diabetes. IUBMB Life. https://doi.org/10.1002/iub.2794
Vancouver
Joshi G, Das A, Verma G, Guchhait P. Viral infection and host immune response in diabetes. IUBMB Life. 2024. doi:10.1002/iub.2794
BibTeX
@article{Joshi2024,
author = {Joshi, Garima and Das, Anushka and Verma, Garima and Guchhait, Prasenjit},
title = {Viral infection and host immune response in diabetes},
journal = {IUBMB Life},
year = {2024},
doi = {10.1002/iub.2794}
}
EUVIMED